Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aditxt Inc.

ADTX
Current price
0.35 USD +0.0072 USD (+2.09%)
Last closed 0.35 USD
ISIN US0070251097
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 5 266 654 USD
Yield for 12 month -99.77 %
1Y
3Y
5Y
10Y
15Y
ADTX
21.11.2021 - 28.11.2021

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Address: 737 North Fifth Street, Richmond, VA, United States, 23219

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

61 USD

P/E ratio

0.0006

Dividend Yield

Current Year

+645 176 USD

Last Year

+933 715 USD

Current Quarter

+6 854 USD

Last Quarter

+44 276 USD

Current Year

-111 660 USD

Last Year

+166 936 USD

Current Quarter

-460 682 USD

Last Quarter

+21 142 USD

Key Figures ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -33 094 198 USD
Operating Margin TTM -13497.11 %
PE Ratio 0.0006
Return On Assets TTM -117.61 %
PEG Ratio
Return On Equity TTM -3493.63 %
Wall Street Target Price 61 USD
Revenue TTM 329 739 USD
Book Value 486.96 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -80 %
Dividend Yield
Gross Profit TTM 166 936 USD
Earnings per share 628.8 USD
Diluted Eps TTM 628.8 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ADTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:40
Payout Ratio
Last Split Date 02.10.2024
Dividend Date

Stock Valuation ADTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.0006
Forward PE 0.3707
Enterprise Value Revenue 70.9472
Price Sales TTM 15.9722
Enterprise Value EBITDA 0.0225
Price Book MRQ 1.1178

Financials ADTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ADTX

For 52 weeks

0.31 USD 380 USD
50 Day MA 2.01 USD
Shares Short Prior Month 910 844
200 Day MA 61.43 USD
Short Ratio 0.16
Shares Short 1 037 887
Short Percent 10.42 %